Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment.
Carnitine level and carnitine palmityl transferase (CPT) activity were investigated in muscles of patients with infantile and juvenile spinal muscular atrophy and polyneuropathies. A significant decrease of both carnitine and CPT was found in the infantile spinal muscular atrophy, but not in the other neurogenic muscle atrophies. These findings were compared with the experimental effect of denervation and reinnervation upon the lipid metabolism in soleus and extensor digitorum longus (EDL) of adult and newborn rats. Twenty-one days after denervation free and total carnitine decreased significantly in both EDL (P less than 0.001) and soleus (P less than 0.05) of adult animals. CPT activity was significantly decreased in the soleus 50 days after denervation (P less than 0.005). Long-term reinnervation restored the level of carnitine fraction and CPT activity. L-carnitine treatment for 21 days restored the level of free carnitine to normal in the soleus of denervated adult animals. Denervation in newborn rats influenced carnitine concentration in soleus and EDL to a lesser extent; the treatment with L-carnitine raised short-chain acylcarnitines in denervated muscles, while reinnervation restored carnitine level within 50 days.
D000217:Acyltransferases / Q000378:metabolism*; D000328:Adult; D000818:Animals; D002331:Carnitine / Q000378:metabolism* / Q000494:pharmacology; D003714:Denervation; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009133:Muscular Atrophy / Q000201:enzymology / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D009416:Nerve Regeneration; D051381:Rats; D011919:Rats, Inbred Strains
D000217:Acyltransferases; D002331:Carnitine